Edward James Tanner III, MD, MBA

Professional Titles

• Medical Director for Women's Health in the National Capital Region
• Vice Chair for National Capital Region, Johns Hopkins Department of Gynecology and Obstetrics

Primary Academic Title

Professor (PAR) of Gynecology and Obstetrics

Background

Centers and Institutes

• Kelly Gynecologic Oncology Service
• Ovarian Cancer Center
• Sidney Kimmel Comprehensive Cancer Center

Videos

• Minimally Invasive Surgery for Gynecologic Cancer Q&A

Recent News Articles and Media Coverage

• New Protocols Protect Patients from Surgical Complications, Johns Hopkins Gynecology & Obstetrics Newsletter (Winter 2018)
• 13 Ovarian Cancer Warning Signs You Should Never Ignore, Fox News (09/2015)
• Advances in Gynecologic Cancer Care and Genetic Testing, Recorded online seminar (09/2015)
• A Green Light for Lymphatic Mapping, Hopkins Medicine Magazine (01/2013)
• For Health Care Providers: Minimally Invasive Surgery for Gynecologic Cancer Q&A (video)

Research Interests

Robotic and Minimally Invasive Surgery for Gynecologic Cancers, Sentinel Lymph Node Mapping of Endometrial Cancer, Surgical Management of Advanced Ovarian Cancer, Fertility Preservation for Cervical and Endometrial Cancer, Management of Uterine Sarcomas, Complex Benign Gynecologic Surgery

PubMed - Publications

http://www.ncbi.nlm.nih.gov/pubmed/?term=Tanner+EJ

Selected Publications

• Tanner E, Black D, Zivanovic O, Kehoe S, Dao F, Konner J, Barakat R, Lichtman S, Levine D. Patterns of First Recurrence Following Adjuvant Intraperitoneal Chemotherapy for Stage IIIC Ovarian Cancer. Gynecol Oncol. 2012; 124 (1): 59-62. PMID: 21982046.

• Tanner E, Chi D, Eisenhauer E, Diaz-Montes T, Santillan A, Bristow R. Early Detection of Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer: Survival Benefit or Lead Time Bias. Gynecol Oncol. 2010; 117(2):336-40. PMID: 20153027.

• Tanner E, Garg K, Leitao M, Soslow R, Hensley M. High Grade Undifferentiated Uterine Sarcoma: Surgery, Treatment, and Survival Outcomes. Gynecol Oncol. 2012; 127 (1): 27-31. PMID: 22750260.

• Tanner E, Leitao M, Garg K, Chi D, Sonoda Y, Gardner G, Barakat R, Jewell E. The Role of Cytoreductive Surgery for Newly Diagnosed Advanced-Stage Uterine Carcinosarcoma. Gynecol Oncol. 2011; 123 (3): 548-52. PMID: 21945551.

• Tanner E, Long K, Feffer J, Leitao M, Abu-Rustum N, Barakat R, Chi D, Gardner G. Parenchymal Splenic Metastasis is an Independent Negative Predictor of Overall Survival in Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancer. Gynecol Oncol. 2012; 128 (1): 28-33. PMID: 23017819.

• Tanner E, Long K, Zhou Q, Brightwell R, Gardner G, Abu-Rustum N, Leitao M, Sonoda Y, Chi D. Impact of Operative Start Time on Surgical Outcomes in Patients Undergoing Primary Cytoreduction for Advanced Ovarian Cancer. Gynecol Oncol. 2012; 126 (1): 58-63. PMID: 22507533.

• Tanner E, Sinno A, Stone R, Levinson K, Long K, Fader A. Factors Associated with Successful Bilateral Sentinel Lymph Node Mapping in Endometrial Cancer. Gynecol Oncol. 2015; [epub ahead of print]. PMID: 26095896.

• Tanner E, Toussaint T, Leitao M, Hensley M, Soslow R, Gardner G, Jewell E. Management of uterine adenosarcomas with and without sarcomatous overgrowth. Gynecol Oncol. 2013; 129 (1): 140-4. PMID: 23283300.

• Tanner E, Zahurak M, Bristow R, Diaz-Montes T. Outcomes of Younger Patients with Ovarian Cancer. Gynecol Oncol. 2008; 111(2): 221-5. PMID: 18786718.

• Barlin J, Long K, Tanner E, Gardner G, Leitao M, Levine D, Sonoda Y, Abu-Rustum N, Chi D. Optimal (≤1cm) but Visible Residual Disease: Is Extensive Debulking Warranted? Gynecol Oncol. 2013; 130 (2): 284-8. PMID: 23672929.

• Cholakian D, Hacker K, Fader A, Gehrig P, Tanner E. Effect of Oral Versus Intrauterine Progestins on Weight in Women Undergoing Fertility Preserving Therapy for Complex Atypical Hyperplasia or Endometrial Cancer. Gynecol Oncol 2015; [epub ahead of print]. 

• Cripe J, Tseng J, Eskander R, Fader A, Tanner E, Bristow R. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Carcinoma: Analysis of 30-Day Morbidity and Mortality. Ann Surg Oncol. 2014; 22(2): 655-61. PMID: 25155402.

• Fader A, Java J, Krivak T, Bristow R, Tergas A, Bookman M, Armstrong D, Tanner E, Gershenson D. The prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian carcinoma: A Gynecologic Oncology Group study. Gynecol Oncol. 2014; 132(3):560-5. PMID: 24333362.

• Fader A, Weise R, Sinno A, Tanner E, Borah B, Moriarty J, Bristow R, Makary M, Pronovost P, Hutfless S, Dowdy S. Utilization of Minimally Invasive Surgery in Endometrial Cancer Care: A Quality and Cost Disparity. Gynecol Oncol 2015; [epub ahead of print]. PMID: 26646127.

• Hyman D, Long K, Tanner E, Grisham R, Arnold A, Bhatia J, Spriggs D, Soslow R, Kauff N, Levine D. Outcomes of Primary Surgical Cytoreduction in Patients with BRCA-associated High-grade Serous Ovarian Carcinoma. Gynecol Oncol. 2012; 126 (2): 224-8. PMID: 22579790.

• Kushnir C, Angarita A, Havrilesky L, Thompson S, Spahlinger D, Sinno A, Tanner E, Secord A, Roche K, Stone R, Fader A. Selective Cardiac Surveillance in Patients with Gynecologic Cancer Undergoing Treatment with Pegylated Liposomal Doxorubicin (PLD). Gynecol Oncol. 2015; 137(3): 503-7. PMID: 25735254.

• Long K, Tanner E, Frey M, Leitao M, Levine D, Gardner G, Sonoda Y, Abu-Rustum N, Barakat R, Chi D. Intraoperative hypothermia during primary surgical cytoreduction for advanced ovarian cancer: Risk factors and associations with postoperative morbidity. Gynecol Oncol. 2013; 131(3): 525-30. PMID: 24016410.

• Pant A, Diaz-Montes T, Tanner E, Ahmad S, Giuntoli R, Holloway R, Bristow R. Correlation of Extreme Drug Resistance Assay Results and Progression Free Survival Following Intraperitoneal Chemotherapy for Advanced Ovarian Cancer. J Chemother. 2010; 22(4): 270-4. PMID: 20685633.

• Ricci S, Giuntoli R, Eisenhauer E, Lopez M, Krill L, Tanner E, Gehrig P, Havrilesky L, Secord A, Levinson K, Frasure H, Celano P, Fader A. Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma? Gynecol Oncol. 2013; 131 (3): 629-33. PMID: 24016408.

• Sandadi S, Tanner E, Khoury-Collado F, Kostolias A, Makker V, Chi D, Sonoda Y, Alektiar K, Barakat R, Abu-Rustum N. Radical surgery with individualized postoperative radiation for stage IB cervical cancer: oncologic outcomes and severe complications. Int J Gynecol Oncol. 2013; 23 (3): 553-8. PMID: 23392402.

• Scheib S, Tanner E, Green I, Fader A. Laparoscopy in the Morbidly Obese: Physiologic Considerations and Surgical Techniques to Optimize Success. J Minim Invasive Gynecol. 2013; 21 (2): 182-95.  PMID: 24100146.

• Shih K, Qin L-X, Tanner E, Zhou Q, Bisogna M, Dao F, Olvera N, Viale A, Barakat R, Levine D. A MicroRNA Survival Signature (MiSS) for Advanced Ovarian Cancer. Gynecol Oncol. 2011; 121 (3): 444-50. PMID: 21354599.

• Sinno A, Tanner E. Robotic Laparoendoscopic Single Site Radical Hysterectomy with Sentinel Lymph Node mapping and Pelvic Lymphadenectomy for Cervical Cancer. Gynecol Oncol. 2015; [epub ahead of print]. PMID: 26307401.

• Sinno A, Fader A, Tanner E. Single Site Robotic Sentinel Lymph Node Biopsy and Hysterectomy in Endometrial Cancer. Gynecol Oncol. 2015; 137(1): 190. PMID: 25684218

• Sinno A, Fader A, Long K, Giuntoli R, Tanner E. A Comparison of Colorimetric versus Fluorometric Sentinel Lymph Node Mapping During Robotic Surgery for Endometrial Cancer. Gynecol Oncol. 2014; 134 (2): 281-6. PMID: 24882555.

• Suidan R, St. Clair C, Lee S, Barlin J, Long Roche K, Tanner E, Sonoda Y, Barakat R, Zivanovic O, Chi D. A comparison of primary intraperitoneal chemotherapy to consolidation intraperitoneal chemotherapy in optimally resected advanced ovarian cancer. Gynecol Oncol. 2014; 134 (3): 468-72. PMID: 25042672.

• Suidan R, Zhou Q, Iasonos A, O'Cearbhaill R, Chi D, Long Roche K, Tanner E, Denesopolis J, Barakat R, Zivanovic O. Prognostic Significance of the Number of Postoperative Intraperitoneal Chemotherapy Cycles for Patients With Advanced Epithelial Ovarian Cancer. Int J Gynecol Cancer. 2015; 25(4): 599-606. PMID: 2566443

Honors

• Excellence in Teaching Award, Johns Hopkins Hospital, 1/1/13
• Virginia K. Pearce Award for Best Poster, Society of Memorial Gynecologic Oncologists Annual Meeting, 1/1/09
• Excellence in Teaching Award, Johns Hopkins Hospital, 1/1/08
• Excellence in Teaching Award, Johns Hopkins Hospital, 1/1/06

Lectures & Presentations

• Fluorometric Imaging for Endometrial Cancer, Invited Lecture, 2nd Fengxian International Forum of Medical Science and Technology, Shanghai, China, 8/30/14
• Introduction of a Sentinel Lymph Node Mapping Program, Endometrial Cancer at Johns Hopkins Hospital, Boston, MA, 12/5/13
• Practical Paradigms for Critical Clinical Challenges in Gynecologic Oncology, Classification and Current Treatment Strategies for Uterine Sarcomas, SGO 2012 State of the Art Conference, Washington, DC, 11/3/12
• Screening for Gynecologic Cancers, Sentara Northern Virginia Medical Center, Woodbridge, 1/3/13
• Screening for Gynecologic Cancers, Grand Round Lectures, Sentara Northern Virginia Medical Center, Woodbridge, VA, 4/3/13
• Screening for Ovarian Cancer, Greater Baltimore Medical Center, Baltimore, 1/19/12
• Screening for Ovarian Cancer, Sibley Memorial Hospital, Washington, 1/4/13
• Screening for Ovarian Cancer, Georgetown/Washington Hospital Center, Washington, 1/24/13
• Screening for Ovarian Cancer, Grand Round Lectures, Greater Baltimore Medical Center, Baltimore, MD, 10/19/12
• Screening for Ovarian Cancer, Grand Round Lectures, Sibley Memorial Hospital, Washington, DC, 3/4/13
• Screening for Ovarian Cancer, Grand Round Lectures, Georgetown/Washington Hospital Center, Washington, DC, 10/24/13
• Sentinel Lymph Node Mapping for Endometrial Cancer, Invited Speaker, Grand Rounds, University of Maryland Department of OB/GYN, Baltimore, MD, 2/13/15
• Single Port Robotic Surgery, Invited Speaker, Surgical Innovations Course, Updates and Innovations in Gynecologic Surgery Course, Johns Hopkins Hospital, Baltimore, MD, 5/29/15
• Techniques, Advantages, and Drawbacks of Single-port Surgery, Invited Lecture, Surgical Innovations Course, Minimally Invasive Therapy Single Incision Laparoscopic Surgery Workshop, Asia-Pacific Association for Gynecologic Endoscopy, Shanghai, China, 11/3/15
• The Skinny on the Mini: Minilaparoscopy, LESS, Robotic Single-Site and the Next Frontier in Alternative Access, Conventional Laparoscopic Access Techniques: A Review and Critical Appraisal, AAGL Annual Meeting, Washington, DC, 11/11/13

Memberships

• American Association of Gynecologic Laparoscopy
• American College of Obstetrics and Gynecology
• Mid-Atlantic Gynecologic Oncology Society
• Society of Gynecologic Oncology
• Society of Memorial Gynecologic Oncologists